Researches

Displaying 51 - 60 of 4042
# Title Department Research Year
51 Design, synthesis, antiproliferative activity, and molecular dynamics simulation of pyrazolinebased derivatives as dual EGFR and HER-2 inhibitors Department of Pharmaceutical Organic Chemistry 2025
52 Design, synthesis, antiproliferative assessments, and computational studies of new quinolin-2(1H)-ones as dual EGFR/HER-2 inhibitors Department of Pharmaceutical Organic Chemistry 2025
53 Design, synthesis, apoptotic antiproliferative, and antioxidant activities of a new series of 2-mercaptobenzimidazole/3-cyanopyridin-2-one hybrids as dual EGFR/BRAFV600E inhibitors Department of Pharmaceutical Organic Chemistry 2025
54 Design, Synthesis, Biological Evaluation, and In Silico Studies of New Nitazoxanide Derivatives: Toward Broad‐Spectrum Antimicrobial Agents Department of Pharmaceutical Organic Chemistry 2025
55 Design, synthesis, in silico studies, and apoptotic antiproliferative activity of novel thiazole-2-acetamide derivatives as tubulin polymerization inhibitors Department of Medicinal Chemistry 2025
56 Design, synthesis, molecular modeling, and antiproliferative evaluation of new 2-oxoindolin-3-ylidene thiazole derivatives Department of Medicinal Chemistry 2025
57 Development of a dual -regimen HPLC-UV method for simultaneous analysis of metformin and donepezil: A study on Diabetic Alzheimers’s patients and pharmacokinetic profiling of metforminin rabbit plasma Department of Pharmaceutical Analytical Chemistry 2025
58 Discovery of a novel 1H-pyrazole -[3,4-d] pyrimidine inhibitor based on phenotypic screening for esophageal cancer: Weak cardiotoxicity Department of Pharmaceutical Organic Chemistry 2025
59 Disposable and sensitive electrochemical magneto-immunosensor for point-of-care HCV diagnostics: Targeting HCVcAg, the active viremia biomarker, in patient samples Department of Pharmaceutical Analytical Chemistry 2025
60 Dual-emission ratiometric fluorometric platform using Cu@NCDs/eosin system for sensitive detection of metformin: Pharmacokinetic studies in normal and disease states Department of Pharmaceutical Analytical Chemistry 2025